Which of the following features is true of Ketamine when addressing its use in children with active upper respiratory infections?

Ketamine is known for its unique properties in pediatric patients, particularly when used in the context of sedation during procedures. One of the notable aspects of ketamine is its effect on oral secretions. When administered, ketamine can lead to increased salivation and mucous secretion. This is particularly relevant in children who may already have respiratory complications due to upper respiratory infections, as these secretions can help to clear the airways and may even provide a protective mechanism during sedation.

In addition to this, while ketamine has various effects on the respiratory system, such as maintaining airway reflexes and not significantly depressing respiratory drive, the stimulation of oral secretions stands out particularly when considering the care of children with active respiratory infections. This can be beneficial in certain contexts, as it helps to keep the airways moist and may assist in managing secretions.

Understanding ketamine's interaction with secretions is crucial for healthcare providers, especially when sedating children who may have compromised respiratory status due to infections.